TREM1 and cancer: TREM-1 inhibitory peptides/proteins, discussed in detail below, are molecules designed to suppress TREM-1 signaling and mitigate excessive inflammatory responses associated with various diseases, including sepsis, ischemia–reperfusion injury, rheumatoid arthritis, and cancer.